Skip to main content

Table 1 Characteristics of patients with HCC

From: Transarterial chemoembolization (TACE) using mitomycin and lipiodol with or without degradable starch microspheres for hepatocellular carcinoma: comparative study

No. of patients 99
Patients age (years) 63.6 (range: 34-83 years)
Male no. (%) 78 (78.8%)
Female no. (%) 21 (21.2%)
Presence of liver cirrhosis (%) 91 (91.9%)
Initial liver disease:
 Hepatitis B 29 (29.3%)
 Hepatitis C 36 (36.4%)
 Hepatitis B and C 9 (9.1%)
 Hemochromatosis 3 (3.0%)
 Alcohol abusus 26 (26.3%)
BCLC-Stage:
 BCLC-Stage A 11 (11.1%)
 BCLC-Stage B 88 (91.9%)
Child-Pugh class:
 A 27 (27.3%)
 B 72 (72.7%)
 Vascular tumor invasion 0%
Confirmation of diagnosis with liver
 Biopsie 99 (100%)
Localisation in liver:
 Right lobar 45% (45.5%)
 Left lobe 5 (5.1%)
 Bilobar 49 (49.4%)
Number of tumor lesions:
 Single 11 (11.1%)
 2 28 (28.3%)
 3 8 (8.1%)
 4 4 (4%)
 Multifocal 48 (48.5%)
Tumor response:
 Partial response 25 (25.3%)
 Stable disease 54 (54.5%)
 Progressive disease 20 (20.2%)